Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Vice President, Scientific Value at GNS Healthcare
Dr. Birgit M. Schoeberl, Ph.D., had served as the Head of Discovery at Merrimack Pharmaceuticals, Inc. since January 2015 until February 24, 2017. Dr. Schoeberl joined Merrimack in 2003. At Merrimack, she has held leadership roles in the creation and development of many of Merrimack's clinical. Dr. Schoeberl was critical to formulating Merrimack's research and development platform, Network Biology. She was key in designing MM-121 and MM-111. She is an internationally recognized leader in the field of systems biology. She serves on the Scientific Advisory Board and as an observer on the Board of Directors of Silver Creek Pharmaceuticals, Inc. She received an M.S. degree in Chemical Engineering from the University of Karlsruhe, Germany and a Ph.D. degree from the Max-Planck- Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany. She did her post-doctoral work in the laboratories of Doug Lauffenburger and Peter Sorger. programs, most notably MM-121. Ms. Schoeberl received her postdoctoral training at Massachusetts Institute of Technology (MIT) where she built some of the earliest computational models of signaling networks